UNICA IRIS Institutional Research Information System

LUPIA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.253
NA - Nord America 1.370
AS - Asia 1.034
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 49
OC - Oceania 4
Totale 20.992
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17.883
US - Stati Uniti d'America 1.312
SG - Singapore 436
CN - Cina 281
BR - Brasile 107
VN - Vietnam 81
DE - Germania 69
HK - Hong Kong 63
FR - Francia 54
BD - Bangladesh 50
FI - Finlandia 46
NL - Olanda 37
SE - Svezia 37
IN - India 30
CA - Canada 28
GB - Regno Unito 26
AT - Austria 24
KR - Corea 23
AR - Argentina 17
RU - Federazione Russa 17
LT - Lituania 16
IQ - Iraq 14
MX - Messico 13
ZA - Sudafrica 10
ES - Italia 9
IE - Irlanda 9
CO - Colombia 8
MA - Marocco 8
EC - Ecuador 7
SC - Seychelles 7
JP - Giappone 6
PY - Paraguay 6
TN - Tunisia 6
VE - Venezuela 6
EG - Egitto 5
PK - Pakistan 5
PL - Polonia 5
ID - Indonesia 4
IL - Israele 4
KE - Kenya 4
SA - Arabia Saudita 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
HN - Honduras 3
HR - Croazia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AU - Australia 2
BE - Belgio 2
CR - Costa Rica 2
EE - Estonia 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PR - Porto Rico 2
RO - Romania 2
SN - Senegal 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LY - Libia 1
MN - Mongolia 1
MQ - Martinica 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UA - Ucraina 1
UG - Uganda 1
Totale 20.867
Salva come PNG Salva come JPEG
Città #
Cagliari 15.965
Uta 1.607
Singapore 288
Ashburn 236
San Jose 193
Boardman 108
Dallas 95
Council Bluffs 64
Hong Kong 61
Hefei 60
Beijing 52
Santa Clara 50
Los Angeles 49
Ho Chi Minh City 36
Helsinki 33
Naples 29
Milan 27
Lauterbourg 26
Rome 25
Hanoi 23
Seoul 23
Columbus 22
Tampa 21
The Dalles 21
New York 19
Vienna 18
Frankfurt am Main 17
Phoenix 17
Munich 16
Vilnius 16
Buffalo 15
Nuremberg 12
Redondo Beach 12
Amsterdam 11
Orem 11
Chicago 10
Lappeenranta 10
São Paulo 10
Washington 10
Dublin 9
Figino 9
Sassari 9
Selargius 9
North Bergen 8
Perugia 8
Brooklyn 7
Chennai 7
Johannesburg 7
Stockholm 7
Atlanta 6
Boston 6
Casablanca 6
Dhaka 6
Richmond 6
Toronto 6
Baghdad 5
Bologna 5
Houston 5
Krefeld 5
London 5
Manchester 5
Salt Lake City 5
San Diego 5
Shanghai 5
Turin 5
Verona 5
Bari 4
Campos dos Goytacazes 4
Düsseldorf 4
Guangzhou 4
Hoorn 4
Medellín 4
New Delhi 4
Newark 4
San Francisco 4
Tokyo 4
Waltham 4
Agrolândia 3
Alliston 3
Biên Hòa 3
Buenos Aires 3
Catania 3
Curitiba 3
Damascus 3
Delhi 3
Denver 3
Dubai 3
Erbil 3
Islington 3
Las Vegas 3
Mexico City 3
Montesilvano Marina 3
Moscow 3
Muscat 3
Nairobi 3
Pacoima 3
Rosignano Marittimo 3
Roubaix 3
Saint Augustine 3
San Pedro Sula 3
Totale 19.602
Salva come PNG Salva come JPEG
Nome #
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 1.296
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 1.154
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 1.065
Current updates on naturally occurring compounds recognizing sars-cov-2 druggable targets 941
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 933
Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma? 925
Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates 853
In silico food-drug interaction: A case study of eluxadoline and fatty meal 850
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 836
Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators 789
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders 778
Peptide platform as a powerful tool in the fight against covid-19 740
null 726
Computer-based techniques for lead identification and optimization II: Advanced search methods 719
Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition 689
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 676
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 618
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 609
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 600
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 574
Computer-based techniques for lead identification and optimization i: Basics 529
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 493
Identification of Compounds Targeting HuD. Another Brick in the Wall of Neurodegenerative Disease Treatment 432
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 397
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 358
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 331
New Structural Features of Isatin Dihydrothiazole Hybrids for Selective Carbonic Anhydrase Inhibitors 329
Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors 322
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B 316
A first-in-class Wiskott-Aldrich syndrome protein activator with anti-tumor activity in hematologic cancers 261
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 228
Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases 199
3D variability analysis reveals a hidden conformational change controlling ammonia transport in human asparagine synthetase 154
Identifying potential allosteric inhibitors of ZIKV NS3pro through a combined computational and biochemical approach 100
Structure-based virtual screening leads to the discovery of a 4,5-dihydropyrazole derivative as the first dual inhibitor of West Nile virus NS3 helicase and protease 38
A combination of MD-derived pharmacophores and structure-based strategy identifies dual allosteric inhibitors of NS2B-NS3 proteases in Zika and West Nile viruses 30
γ-Monoalkyl triphosphate analogues of acyclic nucleoside phosphonates inhibit SARS-CoV-2 replication in vitro by inducing dissociation of the minimal replication-transcription complex 29
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 29
The natural coumarin 7-methoxy-8-isopentenyloxycoumarin alleviates LPS-induced inflammation by suppressing NF-κB and the MAPK/AP-1 pathways and accelerating COX-2 proteasomal degradation 26
Dual inhibitors of SARS-CoV-2 Nsp13 helicase functions with broad anti-hCoV activity and combination effects with approved antivirals 20
Totale 20.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234.313 0 0 0 0 0 13 5 0 31 53 73 4.138
2023/20245.499 1.027 131 156 311 374 756 717 524 221 387 524 371
2024/20257.091 927 1.314 1.389 1.110 496 785 632 59 91 86 81 121
2025/20263.127 259 140 213 178 175 171 579 411 274 261 184 282
2026/2027962 80 185 235 459 3 0 0 0 0 0 0 0
Totale 20.992